ATE501278T1 - Verfahren zur verwendung von il-21 - Google Patents

Verfahren zur verwendung von il-21

Info

Publication number
ATE501278T1
ATE501278T1 AT06792239T AT06792239T ATE501278T1 AT E501278 T1 ATE501278 T1 AT E501278T1 AT 06792239 T AT06792239 T AT 06792239T AT 06792239 T AT06792239 T AT 06792239T AT E501278 T1 ATE501278 T1 AT E501278T1
Authority
AT
Austria
Prior art keywords
individual
predicting
therapy
patient
detecting
Prior art date
Application number
AT06792239T
Other languages
English (en)
Inventor
Hans Yssel
Laurence Gugliemi
Jerome Pene
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE501278T1 publication Critical patent/ATE501278T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06792239T 2005-09-22 2006-09-22 Verfahren zur verwendung von il-21 ATE501278T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71938805P 2005-09-22 2005-09-22
PCT/EP2006/009239 WO2007039147A1 (en) 2005-09-22 2006-09-22 Methods of using il-21

Publications (1)

Publication Number Publication Date
ATE501278T1 true ATE501278T1 (de) 2011-03-15

Family

ID=37649383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06792239T ATE501278T1 (de) 2005-09-22 2006-09-22 Verfahren zur verwendung von il-21

Country Status (10)

Country Link
US (2) US20070111239A1 (de)
EP (2) EP1937838B1 (de)
JP (1) JP5208746B2 (de)
AT (1) ATE501278T1 (de)
AU (1) AU2006299141B2 (de)
CA (1) CA2620338A1 (de)
DE (1) DE602006020601D1 (de)
ES (1) ES2360728T3 (de)
IL (1) IL189597A (de)
WO (1) WO2007039147A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006086846A1 (en) * 2005-02-16 2006-08-24 Genetic Technologies Limited Methods of genetic analysis involving the amplification of complementary duplicons
ATE501278T1 (de) * 2005-09-22 2011-03-15 Inst Nat Sante Rech Med Verfahren zur verwendung von il-21

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020236A1 (en) 1992-04-03 1993-10-14 Applied Biosystems, Inc. Probe composition and method
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
EP0679196B1 (de) 1993-01-07 2004-05-26 Sequenom, Inc. Dns - sequenzierung durch massenspektronomie
US5571676A (en) 1995-06-07 1996-11-05 Ig Laboratories, Inc. Method for mismatch-directed in vitro DNA sequencing
US5773346A (en) 1995-12-06 1998-06-30 Micron Technology, Inc. Semiconductor processing method of forming a buried contact
US6803451B2 (en) 1998-09-23 2004-10-12 Zymogenetics, Inc. Cytokine receptor zalpha11 polypeptides
US6576744B1 (en) 1998-09-23 2003-06-10 Zymogenetics, Inc. Cytokine receptor zalpha11
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
AU2003251633A1 (en) * 2002-07-01 2004-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Il-21 as a regulator of immunoglobin production
US20060177421A1 (en) * 2002-10-11 2006-08-10 Novo Nordisk A/S Treatment of allergic conditions by use of il 21
MXPA05003729A (es) * 2002-10-11 2005-06-17 Novo Nordisk As Tratamiento de condiciones alergicas mediante el uso de il 21.
JP4664684B2 (ja) 2002-12-13 2011-04-06 ザイモジェネティクス， インコーポレイテッド 原核生物宿主におけるｉｌ−２１の生産
ATE501278T1 (de) * 2005-09-22 2011-03-15 Inst Nat Sante Rech Med Verfahren zur verwendung von il-21

Also Published As

Publication number Publication date
US20070111239A1 (en) 2007-05-17
ES2360728T3 (es) 2011-06-08
IL189597A (en) 2012-06-28
EP1937838B1 (de) 2011-03-09
DE602006020601D1 (de) 2011-04-21
WO2007039147A1 (en) 2007-04-12
EP2311995A1 (de) 2011-04-20
JP5208746B2 (ja) 2013-06-12
JP2009508506A (ja) 2009-03-05
AU2006299141A1 (en) 2007-04-12
EP1937838A1 (de) 2008-07-02
AU2006299141B2 (en) 2011-11-24
IL189597A0 (en) 2008-08-07
CA2620338A1 (en) 2007-04-12
US20100291029A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
DK1567667T3 (da) Behandling af Huntington's sygdom med EPA
RS51859B (en) METHOD FOR ANTICIPATING THE RESPONSE TO TREATMENT OF HER DIMENSION INHIBITORS
ATE390925T1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
EP2239262A3 (de) Annellierte heterocyclische Verbindungen als Kinase-Modulatoren
ATE406575T1 (de) Verfahren zur erkennung von medikamentenempfindlichkeit in patienten mit entzündungskrankheiten
ATE406351T1 (de) Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
ATE375518T1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
MX2007006529A (es) Seleccionar pacientes para terapia con un inhibidor her.
MX2009003562A (es) Ensayo elisa para la deteccion de vegf.
ATE329610T1 (de) Anti-april antikörper und hybridomazellen
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
DE602004026910D1 (de) Faseroptische vorrichtung zur wahrnehmung von analyten
BRPI1006215A2 (pt) " anticorpos multiespecíficos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, método de tratamento, método de inibição de uma atividade bíologica e uso do anticorpo "
ATE359508T1 (de) Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke
TNSN07036A1 (en) Human monoclonal antibodies against human il-4
DE602005008325D1 (de) Quantifizierung von Enzymaktivität mittels planarer Wellenleiter
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
DK2005162T3 (da) Screeningsmetode
Ardakani et al. Quantifying the correlation between spatially defined oxygen gradients and cell fate in an engineered three-dimensional culture model
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
DE602005002673D1 (de) Nukleotidsequenzvariation im Gen NS5A als Marker
ATE501278T1 (de) Verfahren zur verwendung von il-21
ATE508201T1 (de) Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1937838

Country of ref document: EP